21025 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)
Neuroprotective peptides that inhibit interaction between palmitoyl acyl transferase zinc-finger DHHC type containing 17 (zD17) and c-jun N-terminal kinase (JNK)
#902Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#903Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor
#904Methods of treating cancer of the central nervous system
#905Predicting and treating diabetic complications
#906WOUND HEALING
#907COMBINATION PRODUCTS FOR TREATING CANCER
#908DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUES
#909Methods and compositions for in vivo induction of pancreatic beta cell formation
#910METHODS OF TREATING ANEMIA AND RED BLOOD CELL DYSFUNCTION WITH LECITHIN CHOLESTEROL ACYLTRANSFERASE
#911Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#912Replication competent pseudo-type retrovirus vector system
#913Composition for preventing or treating rheumatoid arthritis
#914Modified polynucleotides for the production of cosmetic proteins and peptides
#915Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
#916Treatments of oxidative stress conditions
#917Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#918Methods and products relating to GSK3β regulation
#919High-affinity monoclonal antibodies to glypican-3 and use thereof
#920Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#921Cancer stem cell targeted cancer vaccines
#922Methods of treatment of cancer using SRC-modulating peptides
#923Methods and Compositions for Treating Disease
#924Compositions and methods for oxalate reduction
#925Anti-Inflammatory Peptides and Composition Comprising the Same
#926Methods of detecting Akt3 and administering Ax1 inhibitor
#92728 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response
#928Delivery of negatively charged proteins using cationic lipids
#929ENZYME-ASSISTED SPATIAL DECORATION OF BIOMATERIALS
#930METHODS FOR TREATMENT AND DIAGNOSIS OF CANCER
#931Vault and vault like carrier molecules
#932Methods of cytotoxic gene therapy to treat tumors
#933METHODS FOR TREATING AND MONITORING THE STATUS OF CANCER
#934Paramyxovirus immunogens and related materials and methods
#935ANTITUMOR PROTOCOL
#936Delivery system for functional nucleases
#937Use of cationic lipids to deliver CAS9
#938Method of restoring the incretin effect
#939Visfatin therapeutic agents for the treatment of acne and other conditions
#940Modified polynucleotides for the production of proteins
#941Methods and compositions for treating neuropathies
#942Chimeric adenoviruses for use in cancer treatment
#943PEGylated fibrinogen precursor molecule
#944Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
#945Immunogenic compositions and reagents for preparing
#946COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#947Methods for treating cardiac conditions
#948Poxviral oncolytic vectors
#949Combination therapy for the treatment of cancer using an anti-C-met antibody
#950mRNA for use in treatment of human genetic diseases
#951Treatment of ocular neovascularization using anti-VEGF proteins
#952Targeting of chondroitin sulfate glycans
#953Methods and compositions for reducing blood glucose
#954METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN
#955Presbyopia treatment by lens alteration
#956Anti-cancer nanoparticle compositions and methods of use
#957Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof
#958Accumulation of metabolic products in bacterial microcompartments
#959PROCESS FOR CONCENTRATION OF A POLYPEPTIDE
#960Use of GSTP1
#961USE OF COMPOSITIONS HAVING A LOW POLYAMINE CONTENT IN THE PREVENTION OR TREATMENT OF ADVERSE EFFECTS LINKED TO CANCER TREATMENT
#962RbAp48 transgenic mice for drug discovery in age-related memory decline
#963Cleavable lipids
#964Proteomic IPF markers
#965Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#966METHOD FOR THE TREATMENT OF ULCERATIVE COLITIS IN PATIENTS REFRACTORY TO STEROID THERAPY USING LEACHED LIGAND FIBRIN STABILIZING COMPOSITION
#967Methods of administering 3,4-diaminopyridine
#968Modified polynucleotides for treating protein deficiency
#969Compounds, compositions, methods, and kits relating to telomere extension
#970ST6GAL I MEDIATED MODULATION OF HEMATOPOIESIS
#971TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF
#972PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
#973Modified polynucleotides for treating galactosylceramidase protein deficiency
#974Treatment for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
#975Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance
#976Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#977Modified polynucleotides encoding basic helix-loop-helix family member E41
#978PURINE NUCLEOSIDE PHOSPHORYLASE AS ENZYMATIC ACTIVATOR OF NUCLEOSIDE PRODRUGS
#979TREATMENT OF CANCER WITH ALK1 ANTAGONISTS
#980Modified polynucleotides encoding citeD4
#981Methods of Cancer Treatment and Prevention Through the Modulation of SIRT4 Activity
#982MODIFIED POLYNUCLEOTIDES FOR TREATING DOLICHYL-PHOSPHATE (UDP-N-ACETYLGLUCOSAMINE) N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE 1 (GLCNAC-1-P TRANSFERASE) PROTEIN DEFICIENCY
#983COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
#984Bacterial anti-phage defense systems
#985Peptide inhibitors of protein kinase C
#986Compositions and methods relating to argininosucccinate synthetase
#987Multi-chamber applicator for gelatin solution
#988Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
#989Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
#990Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
#991Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#992Modified polynucleotides encoding septin-4
#993Using GNMT as a Novel Therapeutic or Preventing Agent for Fatty Liver Related Diseases
#994Modified polynucleotides encoding granulysin
#995Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#996Modified polynucleotides encoding apoptosis inducing factor 1
#997Modified polynucleotides encoding hepatitis A virus cellular receptor 2
#998Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
#999Modified polynucleotides encoding aquaporin-5
#1000Tumor antigen proteins or genes of polo-like kinase 1
#1001Gene delivery vehicles in the treatment of neurodegenerative diseases
#1002Method for screening a glutamate release inhibitor in an astrocyte
#1003METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS AND ITS APPLICATIONS
#1004Compositions and methods for the treatment of cancer
#1005Prodrug anti-cancer therapy
#1006Melatonin-based treatment and diagnosis of bile duct disease
#1007Complexes of RNA and cationic peptides for transfection and for immunostimulation
#1008Compositions and methods for treating or preventing oxalate-related disease
#1009Compositions and methods for treating cancer
#1010EXTRACTS ISOLATED FROM ELECTROPORATED AMBHIBIAN OOCYTES AND USE THEREOF IN TREATING DISEASES AND DISORDERS
#1011METHODS OF TREATING ANEMIA AND RED BLOOD CELL DYSFUNCTION WITH LECITHIN CHOLESTEROL ACYLTRANSFERASE
#1012Detection of mutations in a gene associated with resistance to viral infection, OAS1
#1013Oligoadenylate synthetase (OAS)
#1014Oligoadenylate synthetase (OAS)
#1015Agent for treating allergic or hypersensitivity condition
#1016USE OF CREATINE KINASE FOR PREVENTING OR TREATING ADDICTION TO OPIATES
#1017PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
#1018Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug
#1019MATERIALS AND METHODS FOR THE PROPHYLACTIC TREATMENT OF A PRE-MALIGNANT CONDITION
#1020COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
#1021Variant activin receptor polypeptides and uses thereof
#1022Screening method for antidiabetic agent using newly identified insulin secretion regulation factor
#1023Poxviral oncolytic vectors
#1024Cyclopropanecarboxylate esters of purine analogues
#1025Indolin-2-one derivatives as protein kinase inhibitors
#1026METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS
#1027Modified polynucleotides for the production of biologics and proteins associated with human disease
#1028Modified polynucleotides for the production of secreted proteins
#1029VEGF-activated trail ligands
#1030METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS
#1031METHODS OF TREATING AND PREVENTING THROMBOTIC DISEASES USING ASK1 INHIBITORS
#1032Chimeric adenoviruses for use in cancer treatment
#1033Compositions and Methods for Treating Neurological Disorders
#1034Method of restoring the incretin effect
#1035Method of deriving mature hepatocytes from human embryonic stem cells
#1036Chimeric adenoviruses for use in cancer treatment
#1037METHOD OF PREVENTING PROGRESSION OF HYPERTENSION-INDUCED HEART FAILURE WITH PKC PEPTIDES
#1038Chimeric adenoviruses for use in cancer treatment
#1039Methods and means for diagnosing spondylarthritis using autoantibody markers
#1040ALK1 Antagonists and Their Uses in Treating Renal Cell Carcinoma
#1041Mobilization of hematopoietic stem cells
#1042COMPOSITION AND METHOD FOR REDUCING ATHEROSCLEROTIC LESIONS
#1043ANCESTRAL SERINE PROTEASE COAGULATION CASCADE EXERTS A NOVEL FUNCTION IN EARLY IMMUNE DEFENSE
#1044METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#1045Compositions and methods for treating cancer and modulating stress granule formation
#1046NEUTRALIZATION OF FLT3 LIGAND AS A LEUKEMIA THERAPY
#1047Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases
#1048Device and method for the controlled delivery of ophthalmic solutions
#1049COMPOSITIONS AND METHODS FOR TARGETING AND TREATING DISEASES AND INJURIES USING ADENO-ASSOCIATED VIRUS VECTORS
#1050Materials and methods for prevention and treatment of RNA viral diseases
#1051Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication
#1052Inhibition of AXL signaling in anti-metastatic therapy
#1053Methods of treating Parkinson's disease using viral vectors
#1054Methods and compositions for reducing interleukin-4 or interleukin-13 signaling
#1055ACTRIIB-FC polynucleotides, polypeptides, and compositions
#1056TOPICALLY ADMINISTERED, SKIN-PENETRATING GLYCOSAMINOGLYCAN FORMULATIONS SUITABLE FOR USE IN COSMETIC AND PHARMACEUTICAL APPLICATIONS
#1057CHOLESTEROL ESTER FOR REDUCING CHOLESTEROL ABSORPTION
#1058Monomeric forms of human aminoacyl-t-RNA synthetases having non-canonical biological activities
#1059Delivery of Cholesteryl Ester to Steroidogenic Tissues
#1060ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#1061POXVIRAL ONCOLYTIC VECTORS
#1062Methods to predict and prevent resistance to taxoid compounds
#1063PROTEIN KINASE C-DELTA INHIBITORS THAT PROTECT AGAINST CELLULAR INJURY AND INFLAMMATION AND PROMOTE ASTROCYTE PROLIFERATION
#1064Modulation of Axon Degeneration
#1065Variant activin receptor polypeptides and uses thereof
#1066Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
#1067DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, OAS1
#1068USE OF PROTEIN ARGININE METHYLTRANSFERASES IN REGULATING HEMATOPOIETIC DIFFERENTIATION
#1069Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#1070Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
#1071Pharmaceutical compositions for the treatment of virus infection
#1072Detection of mutations in a gene associated with resistance to viral infection, OAS1
#1073Chimeric adenoviruses for use in cancer treatment
#1074Vault complexes for cytokine delivery
#1075Use of GSTP1
#1076Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
#1077CELLS GENETICALLY MODIFIED TO COMPRISE PANCREATIC ISLET GLUCOKINASE AND USES THEREOF
#1078Compositions and Methods for Preventing or Treating Influenza Virus Infection
#1079Methods of promoting fat loss comprising administering an ALK7 inhibitor
#1080Lipid vesicle compositions and methods of use
#1081Upregulation of integrin linked kinase (ILK) to provide cardioprotective effects
#1082Further use of protein kinase N beta
#1083Cancer therapy
#1084Method for the treatment of pulmonary disease and method of producing proteins of use therein
#1085REPROGRAMMING CANCER CELLS
#1086mRNA for use in treatment of human genetic diseases
#1087PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS
#1088Methods of use of epsilon inhibitor compounds for the attenuation of pain
#1089Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus
#1090Methods of treating anemia and red blood cell dysfunction with lecithin cholesterol acyltransferase
#1091NEURAL STEM CELL COMPOSITION CAPABLE OF TREATING CANCER AND METHOD OF TREATMENT
#1092COMBINED USE OF CREATINE PHOSPHATE AND CREATINE PHOSPHOKINASE FOR TREATMENT OF ARTERIOSCLEROSIS
#1093STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES
#1094COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV
#1095Process for concentration of a polypeptide
#1096METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS
#1097Targets for Growth Factor Signalling and Methods of Therapy
#1098Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
#1099Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
#1100The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
#1101COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#1102Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer
#1103ALANINE-GLYOXYLATE AMINOTRANSFERASE THERAPEUTICS
#1104Methods for treating adult respiratory distress syndrome
#1105TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS
#1106METHODS AND COMPOSITIONS FOR EXTENDING THE LIFE SPAN AND INCREASING THE STRESS RESISTANCE OF CELLS AND ORGANISMS
#1107Pegylated fibrinogen precursor molecule
#1108METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#1109METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS
#1110Compositions and methods for causing neurite outgrowth
#1111Inositol Pyrophosphates Determine Exocytotic Capacity
#1112PIGGYBAC TRANSPOSON VARIANTS AND METHODS OF USE
#1113Compositions and methods for treating cancer
#1114Aldehyde tags, uses thereof in site-specific protein modification
#1115Recombinant vectors and hosts comprising human glucokinase encoding gene
#1116Peptide inhibitors of protein kinase C
#1117HIV-1 integrase derived stimulatory peptides interfering with integrase—Rev protein binding
#1118USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
#1119Aldehyde tags, uses thereof in site-specific protein modification
#1120Cosmetic Methods And Compositions For Repairing Human Skin
#1121METHODS FOR TREATMENT AND DIAGNOSIS OF CANCER
#1122Biomaterial Compositions and Methods of Use
#1123Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1
#1124Anti-cancer nanoparticle compositions and methods of use
#1125Generation of replication competent viruses for therapeutic use
#1126METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
#1127NEUREGULIN/ERBB SIGNALING AND INTEGRIN
#1128Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
#1129MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM
#1130Methods for treating atherosclerosis
#1131METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF
#1132METHODS OF TREATING HEMORHEOLOGIC ABNORMALITIES IN MAMMALS
#1133Large Form Of Human 2',5'-Oligoadenylate Synthetase OAS3 for Preventing or Treating Infection With Positive-Sense Single-Stranded RNA Viruses
#1134TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS
#1135METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN
#1136Methods and products relating to GSK3β regulation
#1137Enzyme Composition and Use Thereof
#1138INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS
#1139MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS
#1140Anti-tumor immunotherapy
#1141Role of PI3K p110 delta Signaling in Retroviral Infection and Replication
#1142Presbyopia treatment by lens alteration of disulfide bonds and reduction
#1143Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis
#1144Method of restoring the incretin effect
#1145Methods for treating or preventing heart damage with integrin-linked kinase (ILK) compositions
#1146Polypeptide variants of sleeping beauty transposase
#1147USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES
#1148COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION
#1149Inositol Pyrophosphates Determine Exocytotic Capacity
#1150Lymphatic vessel stabilizer
#1151Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#1152Restoration of hearing loss
#1153PEPTIDES DERIVED FROM THE C2 DOMAIN OF EPSILON PKC AND METHODS OF USE, THEREOF
#1154Methods and compositions for modulating immune tolerance
#1155Alpha 5 beta 1 and its ability to regulate the cell survival pathway
#1156Detection of mutations in a gene associated with resistance to viral infection, OAS1
#1157Methods of treating cancer of the central nervous system
#1158IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57
#1159MODULATION OF THE INTEGRIN LINKED KINASE SIGNALING PATHWAY TO PROMOTE CARDIAC CELL PROLIFERATION AND SELF-RENEWAL
#1160THERAPEUTIC COMPOSITIONS
#1161Poxviral oncolytic vectors
#1162METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#1163Controlled release multidrug formulations for spinal cord injury
#1164METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
#1165Materials and methods for prevention and treatment of RNA viral diseases
#1166METHOD FOR RESTORING BMP-RECEPTOR SIGNALING IN A CELL
#1167Poxviral oncolytic vectors
#1168Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
#1169Method of restoring the incretin effect
#1170METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
#1171Method and compositions for prevention and treatment of diabetic and aged skin
#1172Human monoclonal antibodies specific for CD22
#1173Mobilization of hematopoietic stem cells
#1174Thymidylate Kinase Mutants and Uses Thereof
#1175Compositions and methods for the treatment of cancer
#1176SOULUBLE B-N-ACETYLGLUCOSEAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF
#1177Further Use of Protein Kinase N Beta
#1178tPA mutant in the treatment of acute brain injury and neurodegenerative disorders
#1179Compositions and Methods to Promote Neural Cell Growth
#1180Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#1181ALK7 AND MYOSTATIN INHIBITORS AND USES THEREOF
#1182Prodrug anti-cancer therapy
#1183Compositions and method for manipulating PIM-1 activity in circulatory system cells
#1184Hepatitis C virus inhibitors
#1185MEMORY INFLUENCING PROTEIN
#1186METHOD OF PREVENTING AND TREATING ACUTE BRAIN PATHOLOGIES
#1187Pharmaceutical Compositions for treating wouds and related methods
#1188Methods and compositions for treatment of cancer using oncolytic RSV activity
#1189Purification of factor XIII polypeptides from biological materials
#1190Promoter inducible by reactive oxygen species and vector comprising the same
#1191INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH
#1192Method of preventing progression of hypertension-induced heart failure with PKC peptides
#1193Compositions and methods for CaMKII inhibitors and uses thereof
#1194Methods of screening for neoplastic disease states
#1195Methods and compositions for treating neuropathies
#1196Actriib-Fc polynucleotides, polypeptides, and compositions
#1197NOVEL BONE MASS INCREASING AGENT
#1198Oligoadenylate synthetase (OAS)
#1199Compositions for promoting wound healing and treating psoriasis
#1200Dynamic bio-nanoparticle elements